Any antiglucocorticoid vs placeboGeneral functioning: Average endpoint general functioning score (clinically improved) (no data) · people with psychosis1 finding from 1 reviewAntiglucocorticoid and related treatments for psychosis 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 30 participantsLow
Any antiglucocorticoid vs placeboAdverse events: 2. Specific ‐ extrapyramidal symptoms ‐ average endpoint scores ‐ data only for DHEA SHRS total · people with psychosis1 finding from 1 reviewAntiglucocorticoid and related treatments for psychosis 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 30 participantsLow